ArticleJournal of translational medicine2014

Response of recurrent BRAFV600E mutated ganglioglioma to Vemurafenib as single agent.

Francesca del Bufalo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.